Milestone

AriBio Co., Ltd., based in Seongnam-si, South Korea, is a pharmaceutical company primarily focused on developing treatments for neurodegenerative and infectious diseases. Its key areas of focus include Alzheimer's disease, sepsis, and obesity. AriBio also explores the development of functional foods, bio cosmetics, and functional water products. The company employs an advanced, rapid, and integrated drug development platform, ARID, to accelerate the discovery and delivery of novel therapeutics for incurable diseases, thereby promoting overall health.

Ugion is an augmented and virtual reality R&D company that provides marketing display, amusement interaction, and education services.

ImmuneOnco Biopharma, established in June 2015 in Zhangjiang High-Tech Park, Shanghai, is an early-stage biopharmaceutical company focused on developing innovative cancer immunotherapy products. The company aims to combat cancer by reversing immune suppression caused by cancer cells and actively targeting their eradication. ImmuneOnco employs a systematic approach to leverage both the innate and adaptive immune systems, which positions it among the few biotechnology firms globally pursuing this strategy. The company has developed a diverse pipeline of 14 drug candidates, with eight currently undergoing clinical programs. This extensive portfolio underscores ImmuneOnco's deep understanding of cancer biology and immunology, as well as its capability to translate scientific research into viable therapeutic options.

ImmuneOnco Biopharma, established in June 2015 in Zhangjiang High-Tech Park, Shanghai, is an early-stage biopharmaceutical company focused on developing innovative cancer immunotherapy products. The company aims to combat cancer by reversing immune suppression caused by cancer cells and actively targeting their eradication. ImmuneOnco employs a systematic approach to leverage both the innate and adaptive immune systems, which positions it among the few biotechnology firms globally pursuing this strategy. The company has developed a diverse pipeline of 14 drug candidates, with eight currently undergoing clinical programs. This extensive portfolio underscores ImmuneOnco's deep understanding of cancer biology and immunology, as well as its capability to translate scientific research into viable therapeutic options.

Cosemitech (Shanghai) Co., Ltd. is a semiconductor manufacturer based in Shanghai, China, specializing in a range of products including sensor integrated circuits (ICs), power management semiconductors, motor drivers, and automotive system ICs. The company has a strong focus on automotive electronics, with an R&D team that boasts over 12 years of experience in developing integrated circuits specifically for this sector. Cosemitech's products, such as hall switches, gear sensors, LED drivers, and DC to DC switching regulators, are utilized in various applications across Europe and the United States. The company is dedicated to providing innovative solutions in sensor technology, energy management, and industrial control to enhance the functionality and efficiency of modern automotive systems.

Seek-Data is a smart quantitative investment research company.

A Sports Company based in Shanghai,China.

ImmuneOnco Biopharma, established in June 2015 in Zhangjiang High-Tech Park, Shanghai, is an early-stage biopharmaceutical company focused on developing innovative cancer immunotherapy products. The company aims to combat cancer by reversing immune suppression caused by cancer cells and actively targeting their eradication. ImmuneOnco employs a systematic approach to leverage both the innate and adaptive immune systems, which positions it among the few biotechnology firms globally pursuing this strategy. The company has developed a diverse pipeline of 14 drug candidates, with eight currently undergoing clinical programs. This extensive portfolio underscores ImmuneOnco's deep understanding of cancer biology and immunology, as well as its capability to translate scientific research into viable therapeutic options.

Shanghai Ulucu Electronic Technology Co., Ltd. specializes in cloud-based video and network monitoring services, catering to chain enterprises, logistics companies, educational institutions, and government entities. The company offers a comprehensive range of solutions, including research and development, sales, installation, platform operation, and after-sales services for software and hardware. With a robust independent research and development team, Ulucu has made significant advancements in various technologies, such as embedded systems, streaming media transmission, P2P transmission, and cloud server technology, securing multiple national invention patents in the process. Additionally, Ulucu operates a vast national service network, comprising over 300 service stations across all provinces and cities, aimed at providing extensive support to its clients. The company also operates an artificial intelligence platform tailored for new retail environments, which enhances customer interactions through intelligent marketing services, including facial recognition and data analysis to enable personalized shopping experiences.

Maxieye specializes in smart driving and travel solutions, focusing on the development of autonomous driving systems for the transportation sector in China. The company offers a diverse range of products, including the MAXIPILOT1.0 and PLUS, which provide intelligent cruise and pilot assistance features. Maxieye emphasizes cost-effective Level 2 (L2) solutions as well as high-end intelligence for passenger vehicles. Its offerings include full-working-condition, multi-scenario, and cross-platform advanced driver-assistance systems (ADAS) and autonomous driving systems (ADS). These products address a spectrum of technological levels from Level 0 to Level 4, enhancing vehicle safety and driving capabilities through advanced computer vision systems that detect obstacles and oncoming traffic.

YL Entertainment & Sports is an entertainment marketing and industrial investment platform.

LenoMed Medical is a manufacturer of medical devices focused on improving diabetes management. With over 15 years of research and development experience in infusion technology, the company specializes in creating innovative products such as the InnoTech insulin pump, drug infusion pumps, and related disposables. LenoMed is dedicated to enhancing diabetes care through the integration of continuous glucose monitoring technology with their insulin pumps, aiming to provide patients with better treatment options and monitoring capabilities. Their commitment to advancing diabetes management is reflected in their comprehensive diabetes care management system.

Shanghai Ulucu Electronic Technology Co., Ltd. specializes in cloud-based video and network monitoring services, catering to chain enterprises, logistics companies, educational institutions, and government entities. The company offers a comprehensive range of solutions, including research and development, sales, installation, platform operation, and after-sales services for software and hardware. With a robust independent research and development team, Ulucu has made significant advancements in various technologies, such as embedded systems, streaming media transmission, P2P transmission, and cloud server technology, securing multiple national invention patents in the process. Additionally, Ulucu operates a vast national service network, comprising over 300 service stations across all provinces and cities, aimed at providing extensive support to its clients. The company also operates an artificial intelligence platform tailored for new retail environments, which enhances customer interactions through intelligent marketing services, including facial recognition and data analysis to enable personalized shopping experiences.